| Metric | სს სილკ მედიკალ | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾7.9m₾4.7m | ₾2.70bn₾2.32bn |
| Revenue growth | 67.6% | 16.6% |
| Profitability | ||
| EBITDA | ₾853k₾947k | — |
| EBITDA margin | 10.8%20.1% | — |
| Net profit | ₾853k₾947k | ₾1.84bn₾1.33bn |
| Net margin | 10.8%20.1% | 68.1%57.6% |
| Balance sheet | ||
| Total assets | ₾3.8m₾2.9m | ₾39.27bn₾31.39bn |
| Total equity | ₾1.9m₾1.1m | ₾5.63bn₾4.45bn |
| ROE | 44.3%88.4% | 32.6%30.0% |